diadenosine triphosphate has been researched along with uridine diphosphate in 1 studies
Studies (diadenosine triphosphate) | Trials (diadenosine triphosphate) | Recent Studies (post-2010) (diadenosine triphosphate) | Studies (uridine diphosphate) | Trials (uridine diphosphate) | Recent Studies (post-2010) (uridine diphosphate) |
---|---|---|---|---|---|
140 | 0 | 19 | 1,164 | 4 | 536 |
Protein | Taxonomy | diadenosine triphosphate (IC50) | uridine diphosphate (IC50) |
---|---|---|---|
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit | Homo sapiens (human) | 1.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Camden, J; Fischer, B; Weisman, GA; Yelovitch, S | 1 |
1 other study(ies) available for diadenosine triphosphate and uridine diphosphate
Article | Year |
---|---|
Boranophosphate isoster controls P2Y-receptor subtype selectivity and metabolic stability of dinucleoside polyphosphate analogues.
Topics: Animals; Boranes; Calcium; Cell Line, Tumor; Dinucleoside Phosphates; Drug Stability; Humans; Hydrolysis; Models, Molecular; Molecular Conformation; Phosphoric Diester Hydrolases; Purinergic P2Y Receptor Agonists; Pyrophosphatases; Receptors, Purinergic P2Y; Stereoisomerism; Structure-Activity Relationship; Turkey | 2012 |